AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 221 filers reported holding AMICUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $273,511 | -48.8% | 24,797 | -43.0% | 0.00% | -100.0% |
| Q2 2023 | $534,234 | -5.9% | 43,469 | -15.1% | 0.00% | 0.0% |
| Q1 2023 | $567,586 | +8.9% | 51,180 | +19.9% | 0.00% | 0.0% |
| Q4 2022 | $521,245 | -12.8% | 42,690 | -25.4% | 0.00% | 0.0% |
| Q3 2022 | $598,000 | -29.1% | 57,251 | -27.2% | 0.00% | 0.0% |
| Q2 2022 | $844,000 | +54.0% | 78,627 | +35.9% | 0.00% | 0.0% |
| Q1 2022 | $548,000 | -18.5% | 57,877 | -0.6% | 0.00% | 0.0% |
| Q4 2021 | $672,000 | +18.7% | 58,209 | -1.7% | 0.00% | 0.0% |
| Q3 2021 | $566,000 | +11.4% | 59,235 | +12.4% | 0.00% | 0.0% |
| Q2 2021 | $508,000 | +40.3% | 52,722 | +43.8% | 0.00% | 0.0% |
| Q1 2021 | $362,000 | -19.9% | 36,676 | +87.4% | 0.00% | 0.0% |
| Q4 2020 | $452,000 | -46.0% | 19,571 | -67.0% | 0.00% | -50.0% |
| Q3 2020 | $837,000 | +32.6% | 59,285 | +41.7% | 0.00% | 0.0% |
| Q2 2020 | $631,000 | – | 41,825 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |